Search Results - "McBriar, Mark D."
-
1
Therapeutic potential of melanin-concentrating hormone-1 receptor antagonists for the treatment of obesity
Published in Expert opinion on investigational drugs (01-09-2004)“…The compelling genetic and pharmacological evidence implicating melanin-concentrating hormone-1 receptor (MCH-1R) signalling in the regulation of food intake…”
Get more information
Journal Article -
2
The Spongistatins: Architecturally Complex Natural Products-Part Two: Synthesis of the C(29-51) Subunit, Fragment Assembly, and Final Elaboration to (+)-Spongistatin 2
Published in Angewandte Chemie International Edition (05-01-2001)“…An advanced ABCD fragment (see picture) constructed on the way to the total synthesis of the potent antitumor agent (+)‐spongistatin 2 has also been used in a…”
Get full text
Journal Article -
3
The Spongistatins: Architecturally Complex Natural Products-Part One: A Formal Synthesis of (+)-Spongistatin 1 by Construction of an Advanced ABCD Fragment
Published in Angewandte Chemie International Edition (05-01-2001)“…An advanced ABCD fragment (see picture) constructed on the way to the total synthesis of the potent antitumor agent (+)‐spongistatin 2 has also been used in a…”
Get full text
Journal Article -
4
Substituted 4-morpholine N-arylsulfonamides as γ-secretase inhibitors
Published in European journal of medicinal chemistry (29-11-2016)“…The design, synthesis, SAR, and biological profile of a substituted 4-morpholine sulfonamide series of γ-secretase inhibitors (GSIs) were described. In several…”
Get full text
Journal Article -
5
Melanin concentrating hormone receptor antagonists as antiobesity agents: from M2 to MCHR-1
Published in Current topics in medicinal chemistry (01-08-2007)“…Melanin concentrating hormone (MCH) is a cyclic, nonadecapeptide expressed in the CNS of all vertebrates that regulates feeding behavior and energy…”
Get more information
Journal Article -
6
Discovery of Orally Efficacious Melanin-Concentrating Hormone Receptor-1 Antagonists as Antiobesity Agents. Synthesis, SAR, and Biological Evaluation of Bicyclo[3.1.0]hexyl Ureas
Published in Journal of medicinal chemistry (06-04-2006)“…Melanin-concentrating hormone (MCH) is a cyclic, nonadecapeptide expressed in the CNS of all vertebrates that regulates feeding behavior and energy homeostasis…”
Get full text
Journal Article -
7
Discovery of amide and heteroaryl isosteres as carbamate replacements in a series of orally active γ-secretase inhibitors
Published in Bioorganic & medicinal chemistry (01-01-2008)“…The design of amide and heteroaryl amide isosteres as replacements for the carbamate substructure in previously disclosed 2,6-disubstituted piperidine…”
Get full text
Journal Article -
8
Spongipyran synthetic studies. Total synthesis of (+)-spongistatin 2
Published in Tetrahedron (15-08-2009)“…Evolution of a convergent synthetic strategy to access (+)-spongistatin 2 ( 2), a potent cytotoxic marine macrolide, is described. Highlights of the synthesis…”
Get full text
Journal Article -
9
Discovery of Bicycloalkyl Urea Melanin Concentrating Hormone Receptor Antagonists: Orally Efficacious Antiobesity Therapeutics
Published in Journal of medicinal chemistry (07-04-2005)“…Melanin concentrating hormone (MCH) is involved in regulation of food intake and energy homeostasis. Antagonists of the MCH receptor are expected to affect…”
Get full text
Journal Article -
10
Biaryl Ureas as Potent and Orally Efficacious Melanin Concentrating Hormone Receptor 1 Antagonists for the Treatment of Obesity
Published in Journal of medicinal chemistry (28-07-2005)“…Herein, we report a small molecule MCH-R1 antagonist which demonstrates oral efficacy in chronic rodent models. Substituted phenyl biaryl urea derivatives were…”
Get full text
Journal Article -
11
Discovery of 2,4,6-trisubstituted N-arylsulfonyl piperidines as γ-secretase inhibitors
Published in Bioorganic & medicinal chemistry (15-11-2007)“…Development of cis-2,4,6-trisubstituted piperidine N-arylsulfonamides as γ-secretase inhibitors for the potential treatment of Alzheimer’s disease (AD) is…”
Get full text
Journal Article -
12
Bicyclo[3.1.0]hexyl urea melanin concentrating hormone (MCH) receptor-1 antagonists: Impacting hERG liability via aryl modifications
Published in Bioorganic & medicinal chemistry letters (15-08-2006)“…Herein, we report the discovery of an effective strategy to modulate liabilities related to affinity of previously disclosed bicyclohexane MCHR-1 antagonists…”
Get full text
Journal Article -
13
Bicyclic[4.1.0]heptanes as phenyl replacements for melanin concentrating hormone receptor antagonists
Published in Bioorganic & medicinal chemistry (15-05-2006)“…Bicyclic[4.1.0]heptanes were discovered as replacements for the middle phenyl ring of the biphenylamine moiety in order to eliminate its potential mutagenic…”
Get full text
Journal Article -
14
Biaryl diamides as potent melanin concentrating hormone receptor 1 antagonists
Published in Bioorganic & medicinal chemistry letters (01-12-2005)“…Herein, we report the discovery of the potent and selective biaryl diamide derived MCH-R1 receptor antagonist 1, which was identified upon modification of a…”
Get full text
Journal Article -
15
Spongistatin synthetic studies. 1. Construction of a C(29–48) subtarget
Published in Tetrahedron letters (15-12-1997)“…In this Letter, the first in a series of three, we outline our overall strategy and describe the assembly of a C(29–48) EF-ring advanced intermediate for the…”
Get full text
Journal Article -
16
Recent advances in the discovery of melanin-concentrating hormone receptor antagonists
Published in Current opinion in drug discovery & development (01-07-2006)“…In recent years, obesity therapy has become a major focus of pharmaceutical research. The worldwide market for obesity therapeutics has increased dramatically…”
Get more information
Journal Article -
17
The Spongistatins: Architecturally Complex Natural Products-Part Two: Synthesis of the C(29-51) Subunit, Fragment Assembly, and Final Elaboration to (+)-Spongistatin 2 Financial support was provided by the National Institutes of Health (National Cancer Institute) through Grant CA-70329, a NIH Postdoctoral Fellowship to C.S.B., a Japan Society for Promotion of Science Fellowship to N.M., and a Royal Society Fulbright Fellowship to V.A.D. We also thank the Daiichi Pharmaceutical Co., Ltd, and the
Published in Angewandte Chemie International Edition (05-01-2001)Get full text
Journal Article -
18
The Spongistatins: Architecturally Complex Natural Products-Part One: A Formal Synthesis of (+)-Spongistatin 1 by Construction of an Advanced ABCD Fragment Financial support was provided by the National Institutes of Health (National Cancer Institute) through Grant CA-70329, NIH Postdoctoral Fellowships to A.M.B. and W.H.M., a Japan Society for Promotion of Science Fellowship to N.M., and a Royal Society Fulbright Fellowship to V.A.D. We also thank the Daiichi Pharmaceutical Co., Ltd, and the Ta
Published in Angewandte Chemie International Edition (05-01-2001)Get full text
Journal Article -
19
The Spongistatins: Architecturally Complex Natural Products-Part One: A Formal Synthesis of (+)-Spongistatin 1 by Construction of an Advanced ABCD Fragment
Published in Angewandte Chemie (05-01-2001)“…Zwei Fliegen mit einer Klappe: Bei der Totalsynthese des wirksamen Tumortherapeutikums (+)‐Spongistatin 2 wurde die komplexe ABCD‐Struktur hergestellt (siehe…”
Get full text
Journal Article -
20